Selection of Anthrax Toxin Protective Antigen Variants That Discriminate between the Cellular Receptors TEM8 and CMG2 and Achieve Targeting of Tumor Cells
Open Access
- 1 March 2007
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 282 (13) , 9834-9845
- https://doi.org/10.1074/jbc.m611142200
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Anthrax Toxin Receptor 2–Dependent Lethal Toxin Killing In VivoPLoS Pathogens, 2006
- A Soluble Receptor Decoy Protects Rats against Anthrax Lethal Toxin ChallengeThe Journal of Infectious Diseases, 2005
- TEM8 Interacts with the Cleaved C5 Domain of Collagen α3(VI)Cancer Research, 2004
- Alanine-scanning Mutations in Domain 4 of Anthrax Toxin Protective Antigen Reveal Residues Important for Binding to the Cellular Receptor and to a Neutralizing Monoclonal AntibodyJournal of Biological Chemistry, 2003
- Anthrax toxin: structures, functions and tumour targetingExpert Opinion on Biological Therapy, 2003
- Production, recovery and immunogenicity of the protective antigen from a recombinant strain of Bacillus anthracisJournal of Industrial Microbiology & Biotechnology, 2002
- Crystal structure of the anthrax lethal factorNature, 2001
- Identification of the cellular receptor for anthrax toxinNature, 2001
- Crystal Structure of the I Domain from Integrin α2β1Journal of Biological Chemistry, 1997
- An Approach to Random Mutagenesis of DNA Using Mixtures of Triphosphate Derivatives of Nucleoside AnaloguesJournal of Molecular Biology, 1996